Somatic mutations of β-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma

Cancer Letters

Volumn 152, Issue 1, 2000, Pages 45-51

  Jeng, Yung Ming ^a   Wu, Mu Zon ^a   Mao, Tsui Lien ^a   Chang, Mei Hwei ^a   Hsu, Hey Chi ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Catenin; Hepatoblastoma; Mutation

Indexed keywords

BETA CATENIN;

ARTICLE; CELL ADHESION; CHILD; CLINICAL ARTICLE; COLON POLYPOSIS; CONTROLLED STUDY; DELETION MUTANT; GENE EXPRESSION; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; SOMATIC MUTATION;

AMINO ACID SEQUENCE; BETA CATENIN; CHILD; CHILD, PRESCHOOL; CYTOSKELETAL PROTEINS; FEMALE; GENE DELETION; HEPATOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATORS;

EID: 0034724962     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00433-4     Document Type: Article

References (33)

1. Chandra R.S., Stocker J.T. The liver, gallbladder, and biliary tract. Stocker J.T., Dehner L.P. Pediatric Pathology. 1992;703-789 Lippincott, Philadelphia, PA.
2. Haas J.E., Muczynski K.A., Krailo M., Ablin A., Land V., Vietti T.J., Hammond G.D. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer. 64:1989;1082-1095.
3. Giardiello F.M., Offerhaus G.J., Krush A.J., Booker S.V., Tersmette A.C., Mulder J.W., Kelley C.N., Hamilton S.R. Risk of hepatoblastoma in familial adenomatous polyposis. J. Pediatr. 119:1991;766-768.
4. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 65:1991;589-600.
5. Giardiello F.M., Petersen G.M., Brensinger J.D., Luce M.C., Cayouette M.C., Bacon J., Booker S.V., Hamilton S.R. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut. 39:1996;867-869.
6. Kurahashi H., Takami K., Oue T., Kusafuka T., Okada A., Tawa A., Okada S., Nishisho I. Biallelic inactivation of the APC gene in hepatoblastoma. Cancer Res. 55:1995;5007-5011.
7. Oda H., Imai Y., Nakatsuru Y., Hata J., Ishikawa T. Somatic mutations of the APC gene in sporadic hepatoblastomas. Cancer Res. 56:1996;3320-3323.
8. Nagafuchi A., Takeichi M. Transmembrane control of cadherin-mediated cell adhesion: a 94 kDa protein functionally associated with a specific region of the cytoplasmic domain of E-cadherin. Cell Regul. 1:1989;37-44.
9. Ozawa M., Baribault H., Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8:1989;1711-1717.
10. Peifer M. Beta-catenin as oncogene: the smoking gun. Science. 275:1997;1752-1753.
11. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of β-catenin-TCF signaling in colon cancer by mutations in β-catenin or APC. Science. 275:1997;1787-1790.
12. Rubinfeld B., Albert I., Porfiri E., Fiol C., Munemitsu S., Polakis P. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science. 272:1996;1023-1026.
13. Orford K., Crockett C., Jensen J.P., Weissman A.M., Byers S.W. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem. 272:1997;24735-24738.
14. Larabell C.A., Torres M., Rowning B.A., Yost C., Miller J.R., Wu M., Kimelman D., Moon R.T. Establishment of the dorso-ventral axis in Xenopus embryos is presaged by early asymmetries in β-catenin that are modulated by the Wnt signaling pathway. J. Cell. Biol. 136:1997;1123-1136.
15. Funayama N., Fagotto F., McCrea P., Gumbiner B.M. Embryonic axis induction by the armadillo repeat domain of β-catenin: evidence for intracellular signaling. J. Cell. Biol. 128:1995;959-968.
16. Miller J.R., Moon R.T. Analysis of the signaling activities of localization mutants of β-catenin during axis specification in Xenopus. J. Cell. Biol. 139:1997;229-243.
17. Peifer M., Sweeton D., Casey M., Wieschaus E. Wingless signal and Zeste-white 3 kinase trigger opposing changes in the intracellular distribution of armadillo. Development. 120:1994;369-380.
18. Orsulic S., Peifer M. An in vivo structure-function study of armadillo, the β-catenin homologue, reveals both separate and overlapping regions of the protein required for cell adhesion and for wingless signaling. J. Cell. Biol. 134:1996;1283-1300.
19. Yost C., Torres M., Miller J.R., Huang E., Kimelman D. The axis-inducing activity, stability, and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 10:1996;1443-1454.
20. Behrens J., von Kries J.P., Kühl M., Bruhn L., Wedlich D., Grosschedl R., Birchmeier W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature. 382:1996;638-642.
21. Huber O., Korn R., McLaughlin J., Ohsugi M., Herrmann B.G., Kemler R. Nuclear localization of β-catenin by interaction with transcription factor LEF-1. Mech. Dev. 59:1996;3-10.
22. -/- colon carcinoma. Science. 275:1997;1784-1787.
23. Sparks A.B., Morin P.J., Vogelstein B., Kinzler K.W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58:1997;1130-1134.
24. Dashwood R.H., Suzui M., Nakagama H., Sugimura T., Nagao M. High frequency of β-catenin (Ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res. 58:1998;1127-1129.
25. Takahashi M., Fukuda K., Sugimura T., Wakabayashi K. β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced colon tumors. Cancer Res. 58:1998;42-46.
26. de La Coste A., Romagnolo B., Billuart P., Renard C.A., Buendia M.A., Soubrane O., Fabre M., Chelly J., Beldjord C., Kahn A., Perret C. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA. 95:1998;8847-8851.
27. Miyoshi Y., Iwao K., Nagasawa Y., Aihara T., Sasaki Y., Imaoka S., Murata M., Shimano Y. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res. 58:1998;2524-2527.
28. Hsu H.C., Chiou T.J., Chen Z.Y., Lee C.S., Lee P.H., Peng S.Y. Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology. 13:1991;923-928.
29. Rubinfeld B., Robbins P., El-Gamil M., Albert I., Porfiri E., Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science. 275:1997;1790-1792.
30. Nollet F., Berx G., Molemans F., van Roy F. Genomic organization of the human β-catenin gene (CTNNB1). Genomics. 32:1996;413-424.
31. Koch A., Denkhaus D., Albrecht S., Leuschner I., von Schweinitz D., Pietsch T. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res. 59:1999;269-273.
32. Hayashi K., Yandell D.W. How sensitive is PCR-SSCP? Hum. Mutat. 2:1993;338-346.
33. Rubinfeld B., Robbins P., El-Gamil M., Albert I., Porfiri E., Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science. 275:1997;1790-1792.